Though time was limited and there was not much in the realm of possibility to do, the research thus far has concluded that TFF2 is, without a motion of doubt, in breast tumors. On top of that, the research has also concluded that the receptor protein, CXCR4, is in fact on the membrane of MDSCs. Though very informative, this only scratched the proverbial surface.
Future Directions
In the hopefully near future, the research will dive into looking at the reactions between the tumor cells and the TFF2 gene and see the correlation between the TFF2 gene and MDSCs. This would contribute towards the end goal of finding therapies to temporarily disable the MDSC function to allow the immune system to work against cancer cells. This would ensure that the tumor would not be able to take advantage of the very thing that was designed to protect us, as humans. This would be a huge step towards finding a “cure” for cancer, particularly breast cancer.